Valvular Aortic Valve articles

valve_in_valve-compressor

Surgical Bioprosthesis Deterioration: Is the Valve-in-Valve Technique a Good Option?

Surgical Bioprosthesis Deterioration: Is the Valve-in-Valve Technique a Good Option?

The use of surgical bioprostheses has significantly increased, and while they last 15 years or more, in cases where they fail (usually due to stenosis), the decision-making process is challenging. Transcatheter aortic valve replacement (TAVR) is a good alternative for this situation, although information on the subject matter is still scarce. Currently, the only available

Stroke criptogénico y el fin de la controversia sobre el cierre del foramen oval

Combination of Percutaneous Suture Devices after TAVR to Reduce Vascular Complications

Current use of transcatheter aortic valve replacement (TAVR) has increased in intermediate-risk patients and has even been used in low-risk patients. Vascular access-related complications and bleeding are still frequent after transfemoral TAVR, being associated with poor short- and long-term outcomes. Using percutaneous closure devices has allowed operators to close the access site without surgery. The

tavi vs cirugia partner i

Non-Cardiac Surgery After TAVR Is Safe

There are increasingly more patients who have undergone transcatheter aortic valve replacement (TAVR) and require a non-cardiac intervention, or patients with other diseases who need surgery and are diagnosed with aortic stenosis.  In addition, on many occasions, surgery must be performed as soon as possible (as in cases of cancer) or is an emergency procedure.

Highlights SOLACI-SOCIME 2022

SOLACI-SOCIME 2022 | When is indicated the transcatheter treatment of mitral regurgitation

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. Márcio Montenegro, entitled “When is indicated the transcatheter treatment of mitral regurgitation”

Top